Jan E. Dyr

1.9k total citations
104 papers, 1.6k citations indexed

About

Jan E. Dyr is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Jan E. Dyr has authored 104 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 44 papers in Hematology and 30 papers in Molecular Biology. Recurrent topics in Jan E. Dyr's work include Blood properties and coagulation (46 papers), Platelet Disorders and Treatments (21 papers) and Acute Myeloid Leukemia Research (15 papers). Jan E. Dyr is often cited by papers focused on Blood properties and coagulation (46 papers), Platelet Disorders and Treatments (21 papers) and Acute Myeloid Leukemia Research (15 papers). Jan E. Dyr collaborates with scholars based in Czechia, Sweden and United States. Jan E. Dyr's co-authors include Jiřı́ Suttnar, Eduard Brynda, Tomáš Riedel, Pavel Májek, Zuzana Reicheltová, Jaroslav Čermák, Milan Houška, Roman Kotlín, Jiřı́ Homola and Martin Malý and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Jan E. Dyr

99 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan E. Dyr Czechia 22 515 392 347 257 214 104 1.6k
Jiřı́ Suttnar Czechia 20 415 0.8× 339 0.9× 301 0.9× 129 0.5× 50 0.2× 103 1.2k
Jörg Vienken Germany 27 572 1.1× 144 0.4× 87 0.3× 650 2.5× 136 0.6× 76 2.3k
Gottfried Schmer United States 19 417 0.8× 714 1.8× 437 1.3× 112 0.4× 58 0.3× 62 1.9k
Ronald J. Shebuski United States 26 590 1.1× 516 1.3× 290 0.8× 179 0.7× 32 0.1× 72 2.7k
Reto Müggli Switzerland 20 235 0.5× 369 0.9× 247 0.7× 168 0.7× 39 0.2× 41 1.9k
Takayuki Okamoto Japan 26 1.1k 2.0× 103 0.3× 121 0.3× 198 0.8× 44 0.2× 67 2.1k
Vladimir V. Shuvaev United States 37 1.5k 2.9× 224 0.6× 407 1.2× 523 2.0× 90 0.4× 74 3.6k
Stephen J. Everse United States 24 475 0.9× 941 2.4× 747 2.2× 67 0.3× 38 0.2× 43 2.1k
Nancy Martin United States 18 393 0.8× 55 0.1× 232 0.7× 127 0.5× 56 0.3× 47 2.4k
Marilena Crescente United Kingdom 19 249 0.5× 204 0.5× 135 0.4× 214 0.8× 24 0.1× 40 1.2k

Countries citing papers authored by Jan E. Dyr

Since Specialization
Citations

This map shows the geographic impact of Jan E. Dyr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan E. Dyr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan E. Dyr more than expected).

Fields of papers citing papers by Jan E. Dyr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan E. Dyr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan E. Dyr. The network helps show where Jan E. Dyr may publish in the future.

Co-authorship network of co-authors of Jan E. Dyr

This figure shows the co-authorship network connecting the top 25 collaborators of Jan E. Dyr. A scholar is included among the top collaborators of Jan E. Dyr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan E. Dyr. Jan E. Dyr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sovová, Žofie, Jiřı́ Suttnar, & Jan E. Dyr. (2021). Molecular Dynamic Simulations Suggest That Metabolite-Induced Post-Translational Modifications Alter the Behavior of the Fibrinogen Coiled-Coil Domain. Metabolites. 11(5). 307–307. 9 indexed citations
2.
Sovová, Žofie, Pavel Májek, Jiřı́ Suttnar, et al.. (2020). Impact of posttranslational modifications on atomistic structure of fibrinogen. PLoS ONE. 15(1). e0227543–e0227543. 18 indexed citations
3.
Petroková, Hana, Josef Mašek, Milan Kuchař, et al.. (2019). Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders. Pharmaceutics. 11(12). 642–642. 12 indexed citations
4.
Pimková, Kristýna, Pavel Májek, Roman Kotlín, et al.. (2017). Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes. Free Radical Biology and Medicine. 108. 1–7. 14 indexed citations
5.
Májek, Pavel, et al.. (2015). Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups. BioMed Research International. 2015. 1–9. 5 indexed citations
6.
Reicheltová, Zuzana, Tomáš Riedel, Pavel Májek, et al.. (2014). Abnormal Fibrinogen Zlín (γThr21Ile) with Missense Mutation Causing Hypofibrinogenemia. Acta Haematologica. 132(2). 140–143. 1 indexed citations
7.
8.
Kotlín, Roman, et al.. (2012). Fibrinogen Šumperk II: Dysfibrinogenemia in an individual with two coding mutations. American Journal of Hematology. 87(5). 555–557. 10 indexed citations
9.
Májek, Pavel, et al.. (2011). Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1. Journal of Translational Medicine. 9(1). 84–84. 27 indexed citations
10.
Pimková, Kristýna, Markéta Bocková, Kateřina Hegnerová, et al.. (2011). Surface plasmon resonance biosensor for the detection of VEGFR-1—a protein marker of myelodysplastic syndromes. Analytical and Bioanalytical Chemistry. 402(1). 381–387. 55 indexed citations
11.
Kotlín, Roman, et al.. (2010). Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens. Blood Coagulation & Fibrinolysis. 21(7). 640–648. 6 indexed citations
12.
Reicheltová, Zuzana, Martin Malý, Jiřı́ Suttnar, et al.. (2009). Two cases of congenital dysfibrinogenemia associated with thrombosis – Fibrinogen Praha III and Fibrinogen Plzeň. Thrombosis and Haemostasis. 102(9). 479–486. 15 indexed citations
13.
Kotlín, Roman, Tomáš Riedel, Peter Salaj, et al.. (2008). Acquired Dysfibrinogenemia Secondary to Multiple Myeloma. Acta Haematologica. 120(2). 75–81. 28 indexed citations
14.
Kotlín, Roman, Jiřı́ Suttnar, Peter Salaj, et al.. (2008). A novel fibrinogen variant – Liberec: dysfibrinogenaemia associated with γ Tyr262Cys substitution. European Journal Of Haematology. 81(2). 123–129. 9 indexed citations
15.
Suttnar, Jiřı́, et al.. (2006). The adhesion of blood platelets on fibrinogen surface: Comparison of two biochemical microplate assays. Platelets. 17(7). 470–476. 29 indexed citations
16.
Jiroušková, Markéta, et al.. (1997). Comparative study of human monocyte and platelet adhesion to hydrogels in vitro – effect of polymer structure. Journal of Materials Science Materials in Medicine. 8(1). 19–23. 9 indexed citations
17.
Dyr, Jan E. & Jiřı́ Suttnar. (1997). Separation used for purification of recombinant proteins. Journal of Chromatography B Biomedical Sciences and Applications. 699(1-2). 383–401. 32 indexed citations
18.
Liška, Vladimír, Jan E. Dyr, Jiřı́ Suttnar, Ivan Hirsch, & Vladimı́r Vonka. (1994). Production and simple purification of a protein encoded by part of the gag gene of HIV-1 in the Escherichia coli HB101F+ expression system inducible by lactose and isopropyl-β-d-thiogalactopyranoside. Journal of Chromatography B Biomedical Sciences and Applications. 656(1). 127–133. 4 indexed citations
19.
Holada, Karel, Jan E. Dyr, Jiřı́ Suttnar, & Jan Šimák. (1991). Comparison of rat and human major platelet glycoproteins. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 99(2). 399–403. 6 indexed citations
20.
Dyr, Jan E., Birger Blombäck, B. Hessel, & F. Kornalík. (1989). Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B. Biochimica et Biophysica Acta (BBA) - General Subjects. 990(1). 18–24. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiřı́ Suttnar Breakdown of academic impact, for papers by Jörg Vienken Breakdown of academic impact, for papers by Gottfried Schmer Breakdown of academic impact, for papers by Ronald J. Shebuski Breakdown of academic impact, for papers by Reto Müggli Breakdown of academic impact, for papers by Takayuki Okamoto Breakdown of academic impact, for papers by Vladimir V. Shuvaev Breakdown of academic impact, for papers by Stephen J. Everse Breakdown of academic impact, for papers by Nancy Martin Breakdown of academic impact, for papers by Marilena Crescente
Rankless by CCL
2026